Subscribe


PD breaking news – ACCC Lipitor case dismissed

Pfizer’s market power not “substantial” at time of Lipitor offers. 

The Federal Court has dismissed the Australian Competition and Consumer Commission’s (ACCC) anti-competitive conduct case against Pfizer Australia today.

The ACCC allegations related to offers made to pharmacies in early 2012 for the supply of Lipitor and Pfizer’s generic atorvastatin product, with the organisation alleging Pfizer had a substantial degree of market power in the atorvastatin market and was proscribed from using that power to prevent competitive conduct (PD 08 Oct 14).

Justice Flick found that while Pfizer had taken advantage of its market power by engaging in the alleged conduct, this market power was no longer “substantial” at the time the offers were made in January 2012, the ACCC said.

The Justice also found the ACCC had not established that Pfizer had pursued its conduct to deter competitors from engaging in competitive conduct or for the purpose of substantially lessening competition, the organisation said.

Previously, the ACCC said it would seek in excess of $10m for each alleged contravention.

Chairman Rod Sims said the organisation would “carefully consider” the judgement.

“The ACCC brought this case because it raised important public interest issues regarding the conduct of a patent holder nearing the expiry of that patent and what constitutes permissible competitive conduct.”

See tomorrow’s Pharmacy Daily for more information.

This Pharmacy Daily breaking news brought to you by Pharmacy Daily.


The above Breaking News Alert was sent to Pharmacy Daily subscribers on 25 Feb 15

Make a comment...



Established in 2007, Pharmacy Daily is Australia's leading pharmacy industry publication, and is sent as a free subscription to people across the industry as a PDF newsletter every weekday.

Register for Pharmacy Daily trial subscription

To sign up for a free subscription, click on the button at right.

Click here to see a sample issue of Pharmacy Daily.

Click here for more information on subscriptions.

Alternatively, you can search our site via the search box on the right hand side of the page, or find other content below.

Recent Pharmacy Daily articles

26 Feb

Weekly Comment 26 Feb 18 - WELCOME to PD's weekly comment feature. This ...


26 Feb

Dispensary Corner 26 Feb 18 - REPRODUCTION experts have long held the view ...


26 Feb

Low BC awareness - A NEW report published in Public Health ...


26 Feb

Champix cardiac link - NEW research published in the American Journal ...


26 Feb

Pharmacy’s future - ALL APP Conference 2018 attendees are being ...


26 Feb

Pharmacy chronic pain - DESPITE protestations by pharmacists that they have ...


26 Feb

APC consultant call - THE Australian Pharmacy Council (APC) is calling ...


26 Feb

FDA beats EMA - FROM 2007 to 2016, the US Food ...


26 Feb

Cannabis claims challenge - CLAIMS that medical cannabis use has reduced ...


26 Feb

Beauty Prescription bash - PRICELINE Pharmacy transformed Sydney's Randwick Racecourse into ...


23 Feb

Dispensary Corner 23 Feb 18 - DEDICATION to the task, what every company ...


23 Feb

J&J choice employer - THE Johnson & Johnson Family of Companies ...


23 Feb

Abstract submissions - CHOOSING Wisely Australia, an NPS MedicineWise initiative ...


23 Feb

Codeine price hike - SINCE products containing codeine became prescription only ...


23 Feb

My Chemist wins Roy Morgan PoTY - AUSTRALIAN pharmacy retailer My Chemist has taken ...


23 Feb

E-cigs support detox - ELECTRONIC cigarettes, used as an alternative form ...


23 Feb

New $35m global Ego HQ - FEDERAL Minister for Health Greg Hunt officially ...


23 Feb

Blackmores profit up 20% - BLACKMORES has reported overall group revenue was ...


23 Feb

MCC on cautionary RACP - AUSTRALIA'S peak medical cannabis industry group, the ...


22 Feb

PD breaking news – Blackmores H1 profit up 20% - Blackmores H1 profit up 20%Blackmores has reported ...



Show Pharmacy Daily items by month: